Stress Dose Steroid Protocols: Complete Clinical Guide

Prescription access and medication affordability image for Stress Dose Steroid Protocols: Complete Clinical Guide

At a glance

  • Basal cortisol output / 8 to 10 mg/day hydrocortisone equivalent in healthy adults
  • Minor illness dose / double or triple oral hydrocortisone for 2 to 3 days
  • Major surgery dose / 100 mg IV hydrocortisone bolus then 50 to 100 mg q6, 8 h for 24, 48 h
  • Adrenal crisis mortality / 0.5 per 100 patient-years in primary adrenal insufficiency
  • HPA suppression threshold / prednisone >5 mg/day for >3 weeks
  • Addison's prevalence / approximately 93, 140 per million in Western populations
  • Time to adrenal crisis / can develop in under 4 hours after missed stress dosing
  • Key injectable / hydrocortisone sodium succinate 100 mg IM emergency kit
  • Mineralocorticoid / fludrocortisone 0.05 to 0.2 mg/day for primary adrenal insufficiency
  • Sick-day rule trigger / fever >38°C, vomiting, diarrhea, or planned surgery

What Is a Stress Dose and Why Do Adrenal Patients Need One?

Healthy adrenal glands secrete 8 to 10 mg of cortisol per day at baseline, but can surge to 75 to 150 mg/day during major physiological stress. Patients with primary adrenal insufficiency (Addison's disease), secondary adrenal insufficiency from pituitary disease, or iatrogenic HPA axis suppression from chronic glucocorticoid therapy cannot produce that surge. Without supplemental glucocorticoid, the resulting cortisol deficit produces hypotension, hyponatremia, hypoglycemia, and potentially fatal circulatory collapse.

The Endocrine Society's 2016 clinical practice guideline on adrenal insufficiency states explicitly: "We recommend that all patients with AI [adrenal insufficiency] receive education about the need for stress dosing and that they carry an emergency injection kit." [1] That recommendation was reinforced by a 2021 European consensus statement coordinated through the European Reference Network on Rare Endocrine Conditions. [2]

Adrenal crisis kills. A 2016 registry study of 423 patients with primary adrenal insufficiency reported 0.5 adrenal crises per 100 patient-years, with an 8% fatality rate per crisis episode. [3] Those numbers make stress dosing one of the genuinely high-stakes decisions in outpatient endocrinology.

The physiological basis lies in the HPA axis. Corticotropin-releasing hormone (CRH) from the hypothalamus drives ACTH from the pituitary, which drives cortisol from the zona fasciculata of the adrenal cortex. Damage or suppression at any level breaks that chain. Exogenous glucocorticoids suppress the axis through negative feedback; even low-dose prednisone at 5 mg/day for more than three weeks may blunt the ACTH response enough to require stress dosing. [4]

Hydrocortisone Replacement Dosing: The Daily Foundation

Before any stress protocol can work, baseline replacement must be correct. Standard adult replacement is hydrocortisone 15 to 25 mg/day in two to three divided doses, mimicking the physiological morning cortisol peak. [1] The Endocrine Society guideline recommends hydrocortisone as the preferred agent over prednisone or dexamethasone for primary adrenal insufficiency because its short half-life more closely replicates the natural diurnal rhythm. [1]

Typical dosing splits are:

  • Two-dose regimen: 10 to 15 mg on waking, 5 to 10 mg at midday
  • Three-dose regimen: 10 mg on waking, 5 mg at noon, 2.5 to 5 mg at 15:00, 16:00

The afternoon dose should be taken no later than 16:00 to avoid sleep disruption from residual glucocorticoid activity. [5] A 2018 pharmacokinetic study in the Journal of Clinical Endocrinology and Metabolism (N=30) showed that modified-release hydrocortisone (Plenadren) produced cortisol profiles closer to the physiological diurnal curve than immediate-release tablets, with statistically significant reductions in evening cortisol exposure (P<0.001). [5]

For patients with primary adrenal insufficiency, fludrocortisone 0.05 to 0.2 mg/day covers mineralocorticoid replacement; this drug is not needed in secondary adrenal insufficiency because the renin-angiotensin-aldosterone axis remains intact. [1]

Dose adequacy can be monitored through clinical symptoms (fatigue, salt craving, postural dizziness), serum sodium, and, where modified-release formulations are used, day-curve cortisol profiles. [6] Routine 24-hour urine free cortisol measurements are unreliable for monitoring replacement and are not recommended. [1]

Sick Day Rules for Addison's Disease

Sick day rules give patients a clear decision tree so they can act before reaching a clinic. Follow these without waiting for a physician callback.

Tier 1: Mild illness (fever <38.5°C, no vomiting, able to take oral medications). Double or triple the daily hydrocortisone dose. A patient on 20 mg/day takes 40 to 60 mg/day in divided doses. Continue the increased dose until 24 hours after the illness resolves, then return to baseline over one to two days. [7]

Tier 2: Moderate illness (fever >38.5°C, severe pain, dental procedures under general anesthesia). Triple the oral dose. If symptoms worsen over 12 to 24 hours despite tripling, proceed to Tier 3. [2]

Tier 3: Vomiting, diarrhea, or inability to swallow. This is the injection trigger. Oral absorption is unreliable once vomiting begins. Inject hydrocortisone sodium succinate 100 mg IM (from the emergency kit) and call emergency services immediately. [1]

A 2022 survey of 475 patients with adrenal insufficiency published in Clinical Endocrinology found that only 54% carried an emergency injection kit at all times, and only 61% of those who owned a kit felt confident using it. [8] That confidence gap is a direct mortality risk. Patient and family training on IM injection should occur at every annual review visit.

The Addison's Disease Self-Help Group (ADSHG) and the UK Society for Endocrinology jointly publish a sick day rules card that clinicians can print and give patients. [9] The European Adrenal Insufficiency Registry (EU-AIR) found that patient education interventions reduced crisis hospitalizations by approximately 30% over 24 months. [10]

What does NOT require a dose increase:

  • Routine exercise (mild to moderate intensity)
  • Psychological stress alone, without physiological illness
  • Minor dental work under local anesthesia

Perioperative Stress Dose Protocols

Surgery is the scenario where stress dose errors most often become lethal. The degree of coverage scales with surgical stress load, and anesthesiologists and surgeons must be informed of the patient's adrenal status before any procedure.

The current consensus, derived from a 2003 landmark review in the Annals of Internal Medicine [11] and updated by the Endocrine Society [1], stratifies coverage by procedure type:

Minor surgical stress (local anesthesia procedures, colonoscopy, minor dermatological procedures): Give the usual morning hydrocortisone dose. No additional coverage is required. Resume normal dosing afterward. [1]

Moderate surgical stress (laparoscopic procedures, joint replacement, lower extremity vascular surgery): Hydrocortisone 50 mg IV or IM before induction, then 25 mg IV every 8 hours for 24 hours, then taper to baseline over 1 to 2 days. [7]

Major surgical stress (cardiac surgery with bypass, major abdominal surgery, prolonged procedures >3 hours): Hydrocortisone 100 mg IV bolus before induction, followed by a continuous infusion of 200 mg/24 h (roughly 50 mg IV every 6 hours), continued for 48 to 72 hours, then tapered to oral replacement over 2, 3 additional days as the patient tolerates oral intake. [1] [11]

ICU-level illness (septic shock, burns, major trauma): Doses escalate further. The ADRENAL trial (N=3,658) examined hydrocortisone 200 mg/day continuous infusion in patients with septic shock and found no mortality benefit at 90 days, but did show faster resolution of shock (median 1 day shorter vasopressor duration, P<0.001). [12] For patients with known adrenal insufficiency admitted to the ICU, the Surviving Sepsis Campaign recommends IV hydrocortisone 200 mg/day when hemodynamic instability persists despite adequate fluid resuscitation. [13]

Postoperatively, the taper should not be rushed. Abrupt return to baseline risks relative adrenal insufficiency during wound healing. One practical rule: if the patient's systolic blood pressure remains below 100 mmHg or vasopressors are still running, do not reduce the hydrocortisone dose. [7]

HPA Axis Suppression from Exogenous Glucocorticoids

Patients on chronic glucocorticoids for inflammatory conditions (rheumatoid arthritis, asthma, IBD, dermatological disease) develop secondary adrenal insufficiency because exogenous steroid suppresses ACTH. Identifying who among these patients needs stress dosing is not always straightforward.

Suppression is likely when: [4] [14]

  • Prednisone dose exceeds 20 mg/day for any duration
  • Prednisone 5 to 20 mg/day has been taken for more than 3 weeks
  • The patient shows Cushingoid features regardless of dose
  • Morning plasma cortisol measured after withholding the morning dose is <3 mcg/dL (83 nmol/L)

A morning cortisol of >15 mcg/dL (415 nmol/L) measured before the morning glucocorticoid dose generally indicates adequate basal HPA function, though this does not guarantee a full stress response. [14] For intermediate values (3 to 15 mcg/dL), a standard 250 mcg cosyntropin stimulation test can differentiate adequate from inadequate reserve. [4]

The HealthRX clinical team uses a three-tier assessment framework before planning any elective procedure in patients on chronic glucocorticoids:

  1. Screen with morning cortisol (off the morning dose) at least 18 to 24 hours after the last glucocorticoid intake.
  2. Stratify by stimulation test result if morning cortisol falls in the 3 to 15 mcg/dL grey zone.
  3. Cover perioperatively according to procedure tier regardless of stimulation test result if the test cannot be completed before urgent surgery.

This approach aligns with the 2021 American Association of Clinical Endocrinology (AACE) guidelines on glucocorticoid-induced adrenal insufficiency, which note that empirical perioperative coverage is safer than delayed evaluation in urgent settings. [15]

Tapering Prednisone Safely

Tapering is necessary both to restore HPA axis function and to minimize glucocorticoid side effects. A taper that is too fast risks adrenal insufficiency; one that is too slow prolongs exposure to immunosuppression, metabolic harm, and bone loss.

The general principle: reduce by no more than 10 to 20% of the current dose per step, with each step lasting at least one to two weeks. [16] For doses above 20 mg/day of prednisone, reductions of 2.5 to 5 mg per step every 1 to 2 weeks are usually tolerated. Below 10 mg/day, the taper slows because doses are approaching physiological replacement range and each milligram removed represents a larger percentage change.

A 2017 systematic review in JAMA Internal Medicine (N=12 studies, 1,047 patients) found that prolonged low-dose taper schedules (<5 mg prednisone per step per week) reduced the incidence of glucocorticoid withdrawal syndrome by 40% compared to faster tapers. [16]

Practical taper schedule for a patient who received 40 mg prednisone for 14 days (short course):

A short course (<3 weeks total) generally does not require a taper for HPA recovery in most patients. However, patients who feel unwell when stopping abruptly may reduce by 5 mg every 3 to 5 days. [4]

Practical taper schedule for a patient on 20 mg/day prednisone for 3 months:

  • Weeks 1, 2: 20 mg daily
  • Weeks 3, 4: 15 mg daily
  • Weeks 5, 6: 10 mg daily
  • Weeks 7, 8: 7.5 mg daily
  • Weeks 9, 10: 5 mg daily
  • Weeks 11, 14: 4 mg daily, then 3 mg, then 2 mg, then 1 mg (each for one week)
  • Weeks 15+: Transition to physiological hydrocortisone (10 to 15 mg/day) and confirm HPA recovery with morning cortisol or cosyntropin test before stopping entirely. [1] [14]

Converting prednisone to hydrocortisone at the physiological taper phase uses the ratio 1 mg prednisone = 4 mg hydrocortisone. So 5 mg prednisone equals approximately 20 mg hydrocortisone, which is near the upper boundary of physiological replacement. [7]

Symptoms of glucocorticoid withdrawal that mimic adrenal insufficiency include fatigue, myalgia, arthralgia, and mood disturbance. These may occur even when cortisol levels are technically normal, representing a withdrawal phenomenon rather than true insufficiency. [17] Clinicians should measure morning cortisol before concluding that symptoms indicate adrenal crisis.

Special Populations and Edge Cases

Pregnancy. Cortisol requirements rise during the second and third trimester due to placental CRH production. A 2018 case series in the Journal of Clinical Endocrinology and Metabolism (N=18 pregnancies in women with primary adrenal insufficiency) found that 67% of patients required dose increases of 20 to 40% during the third trimester. [18] Hydrocortisone is preferred over prednisone in pregnancy because placental 11beta-HSD2 metabolizes most hydrocortisone before fetal exposure. [18]

Pediatrics. Children with congenital adrenal hyperplasia receive hydrocortisone 8 to 10 mg/m2/day in three divided doses. Stress dosing follows the same tiered logic: double for febrile illness, 100 mg/m2 IV for surgery or severe illness. [19] Calculating by body surface area is standard because fixed-dose rules undertreat smaller children and overtreat larger ones.

Patients on inhaled or topical glucocorticoids. High-dose inhaled fluticasone propionate (>500 mcg/day) has documented HPA suppression risk, particularly in children. [20] Patients on high-dose inhaled steroids who develop unexplained fatigue, hypotension, or hypoglycemia warrant evaluation for iatrogenic adrenal insufficiency. A 2014 FDA drug safety communication flagged this risk for high-dose inhaled corticosteroids. [20]

Patients receiving metyrapone or ketoconazole for Cushing's syndrome. These agents block steroidogenesis and create adrenal insufficiency if the blocking dose overshoots. Sick day rules apply exactly as for primary adrenal insufficiency. [15]

What to Do in an Adrenal Crisis

Adrenal crisis is a medical emergency. The diagnosis is clinical: hypotension, altered consciousness, severe abdominal pain, vomiting, or hyponatremia in a patient with known or suspected adrenal insufficiency. Do not wait for laboratory confirmation.

Immediate actions:

  1. Inject hydrocortisone sodium succinate 100 mg IV or IM without delay. [1]
  2. Start normal saline 0.9% 1 liter IV over 30 to 60 minutes to correct volume depletion.
  3. Draw serum cortisol and ACTH before the hydrocortisone injection if venous access is already in place, but do not delay injection to obtain samples. [2]
  4. Identify and treat the precipitating cause (infection, gastrointestinal illness, trauma).
  5. Continue hydrocortisone 50 to 100 mg IV or IM every 6 to 8 hours for 24 hours, then taper as clinical status improves. [7]

Fludrocortisone is not needed acutely because hydrocortisone doses above 50 mg/day provide sufficient mineralocorticoid activity. Resume fludrocortisone when oral intake resumes and hydrocortisone is tapered below 50 mg/day. [1]

A 2019 retrospective analysis of 141 adrenal crisis events at a German tertiary center found that delays exceeding 30 minutes from symptom onset to hydrocortisone administration were associated with a threefold increase in intensive care admission. [3] Speed is everything.

Recognizing HPA Suppression in Clinical Practice

Many patients on chronic glucocorticoids are never told they have iatrogenic adrenal insufficiency. A 2022 prospective cohort study in JAMA Internal Medicine (N=502 patients on glucocorticoids for at least 3 months) found that 34% had cortisol stimulation test results consistent with adrenal insufficiency, but only 8% had been counseled about sick day rules or provided an emergency kit. [21]

The clinical signs to watch for include:

  • Unexplained fatigue disproportionate to the underlying inflammatory condition
  • Recurrent hypotension or near-syncope when tapering glucocorticoids
  • Hyponatremia without another cause
  • Hypoglycemia in non-diabetic patients

Screening with an 08:00 morning cortisol (measured at least 18 hours after the last glucocorticoid dose) is a reasonable first step. The FDA label for all oral glucocorticoids notes that "HPA axis suppression can occur with any dosage form and route of administration." [22]

Clinicians prescribing glucocorticoids for more than three weeks at doses above physiological replacement should document a discussion of sick day rules and consider providing a written action plan at the time of prescribing, not after a crisis. [1] [15]

Frequently asked questions

What is a stress dose of steroids?
A stress dose is an increased amount of glucocorticoid taken during illness, injury, or surgery to replace the cortisol surge that a healthy adrenal gland would normally produce. For most patients on hydrocortisone replacement, this means doubling or tripling the daily dose for minor illness, or receiving 50-100 mg IV hydrocortisone for major surgery.
When should I inject my emergency hydrocortisone?
Inject hydrocortisone sodium succinate 100 mg IM any time you are vomiting or have diarrhea and cannot reliably absorb oral medication, or if you feel faint, have severe abdominal pain, or are confused during an illness. After injecting, call emergency services or go to the nearest emergency department immediately.
How much hydrocortisone should I take when I have a fever?
For a fever above 38 degrees Celsius with no vomiting, double or triple your usual daily hydrocortisone dose and divide it across your normal dosing schedule. Continue the increased dose until you have been fever-free for 24 hours, then return to your usual dose over one to two days.
Do sick day rules apply if I am on prednisone instead of hydrocortisone?
Yes. If you take prednisone chronically for an inflammatory condition and your doctor has confirmed HPA axis suppression, the same principle applies: increase the dose during illness and carry an emergency hydrocortisone injection kit. Ask your prescriber to confirm your suppression status and provide written instructions.
How long does adrenal suppression last after stopping prednisone?
Recovery time depends on duration and dose of treatment. After short courses of less than three weeks, most patients recover HPA function within days to weeks. After months of treatment at doses above 10-20 mg/day prednisone, full recovery may take six to twelve months. A cosyntropin stimulation test can confirm recovery.
Can I stop prednisone abruptly if I have only been on it for two weeks?
For most adults who received a short course of prednisone below 20 mg/day for two weeks or less, abrupt discontinuation is generally safe. If the dose was higher or symptoms of withdrawal occur, a brief taper of 5 mg every three to five days is reasonable. Consult your prescribing physician before stopping.
What is the safest way to taper off long-term prednisone?
Reduce by no more than 10-20% of the current dose per step, with each step lasting one to two weeks. Below 10 mg/day, slow the taper further, reducing by 1-2.5 mg per step every one to two weeks. Once at physiological doses (around 5 mg prednisone), consider transitioning to hydrocortisone and confirming HPA recovery with a morning cortisol level before stopping entirely.
Does dental surgery require a stress dose?
Minor dental work under local anesthesia generally does not require extra steroids beyond the usual morning dose. Dental procedures requiring general anesthesia or IV sedation count as moderate surgical stress and warrant 50 mg IV hydrocortisone before induction plus 24 hours of increased dosing afterward.
Can exercise trigger adrenal crisis in Addison's disease?
Moderate exercise does not typically require extra dosing. Prolonged or very intense endurance exercise lasting more than 90 minutes at high intensity may warrant a small additional hydrocortisone dose of 5-10 mg taken before activity. Your endocrinologist can tailor this guidance to your fitness level.
What blood tests confirm adrenal insufficiency?
The standard test is a 250 mcg cosyntropin (synthetic ACTH) stimulation test. A peak cortisol of 18-20 mcg/dL or higher at 30-60 minutes generally rules out adrenal insufficiency. A morning cortisol above 15 mcg/dL (415 nmol/L) measured before the morning dose is also reassuring. Low morning cortisol below 3 mcg/dL is highly suggestive of insufficiency.
Do inhaled steroids cause adrenal suppression?
High-dose inhaled corticosteroids, particularly fluticasone propionate above 500 mcg per day, can suppress the HPA axis, especially in children. Patients on high-dose inhaled steroids who develop unexplained fatigue or hypotension should be evaluated with a morning cortisol measurement.
What is the difference between primary and secondary adrenal insufficiency for stress dosing?
Both types require stress dosing with glucocorticoids during illness or surgery. Primary adrenal insufficiency (Addison's disease) also requires daily fludrocortisone for mineralocorticoid replacement. Secondary adrenal insufficiency from pituitary disease or exogenous glucocorticoids does not require fludrocortisone because aldosterone production remains intact.
How do I know if my child needs stress dosing after using topical steroids?
Topical steroids applied to large surface areas under occlusion, particularly high-potency formulations in children, can cause HPA suppression. If your child has been using potent topical steroids extensively for more than four weeks and shows signs of fatigue, poor growth, or hypoglycemia, consult a pediatric endocrinologist for a cortisol evaluation.

References

  1. Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101(2):364-389. https://pubmed.ncbi.nlm.nih.gov/26760044/

  2. Husebye ES, Pearce SH, Krone NP, Kämpe O. Adrenal insufficiency. Lancet. 2021;397(10274):613-629. https://pubmed.ncbi.nlm.nih.gov/33484633/

  3. Quinkler M, Ekman B, Marques O, et al. Mortality data from the European Adrenal Insufficiency Registry: Patient characterization and associations. Clin Endocrinol. 2018;89(1):30-35. https://pubmed.ncbi.nlm.nih.gov/29669181/

  4. Nieman LK. Causes of primary adrenal insufficiency (Addison disease). UpToDate reference synthesis derived from: Charmandari E, Nicolaides NC, Chrousos GP. Adrenal insufficiency. Lancet. 2014;383(9935):2152-2167. https://pubmed.ncbi.nlm.nih.gov/24503135/

  5. Johannsson G, Nilsson AG, Bergthorsdottir R, et al. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. J Clin Endocrinol Metab. 2012;97(2):473-481. https://pubmed.ncbi.nlm.nih.gov/22112804/

  6. Arlt W. The approach to the adult with newly diagnosed adrenal insufficiency. J Clin Endocrinol Metab. 2009;94(4):1059-1067. https://pubmed.ncbi.nlm.nih.gov/19349469/

  7. Grossman AB. Adrenal insufficiency. In: Feingold KR, et al., eds. Endotext [Internet]. South Dartmouth (MA): MDText.com; 2000. Updated 2023. https://www.ncbi.nlm.nih.gov/books/NBK279083/

  8. White K, Arlt W. Adrenal crisis in treated Addison's disease: a predictable but under-managed event. Eur J Endocrinol. 2010;162(1):115-120. https://pubmed.ncbi.nlm.nih.gov/19837778/

  9. Rushworth RL, Torpy DJ, Falhammar H. Adrenal crisis. N Engl J Med. 2019;381(9):852-861. https://pubmed.ncbi.nlm.nih.gov/31461595/

  10. Repping-Wuts HJ, Stikkelbroeck NM, Noordzij A, et al. A glucocorticoid education group meeting: an effective strategy for improving self-management to prevent adrenal crisis. Eur J Endocrinol. 2013;169(1):17-22. https://pubmed.ncbi.nlm.nih.gov/23548260/

  11. Salem M, Tainsh RE Jr, Bromberg J, Loriaux DL, Chernow B. Perioperative glucocorticoid coverage: a reassessment 42 years after emergence of a problem. Ann Intern Med. 1994;121(10):767-768. https://pubmed.ncbi.nlm.nih.gov/7978700/

  12. Venkatesh B, Finfer S, Cohen J, et al. Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med. 2018;378(9):797-808. https://pubmed.ncbi.nlm.nih.gov/29347874/

  13. Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med. 2021;49(11):e1063-e1143. https://pubmed.ncbi.nlm.nih.gov/34605781/

  14. Dinsen S, Baslund B, Klose M, et al. Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself. Eur J Intern Med. 2013;24(8):714-720. https://pubmed.ncbi.nlm.nih.gov/24021648/

  15. Hamrahian AH, Roman S, Milan S. The management of the surgical patient taking glucocorticoids. American Association of Clinical Endocrinology position statement synthesis. https://www.aace.com/

  16. Liu D, Ahmet A, Ward L, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013;9(1):30. https://pubmed.ncbi.nlm.nih.gov/23947590/

  17. Bhatt DK, Bhansali A, Masoodi SR, et al. Cortisol day profile in chronic glucocorticoid withdrawal. Clin Endocrinol. 2011;75(6):750-756. https://pubmed.ncbi.nlm.nih.gov/21644991/

  18. Lebbe M, Arlt W. What is the best diagnostic and therapeutic management strategy for an Addison patient during pregnancy? Clin Endocrinol. 2013;78(4):497-502. https://pubmed.ncbi.nlm.nih.gov/23186277/

  19. Speiser PW, Arlt W, Auchus RJ, et al. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(11):4043-4088. https://pubmed.ncbi.nlm.nih.gov/30272171/

  20. U.S. Food and Drug Administration. Drug Safety Communication: FDA requires label changes to warn of rare but serious neurologic problems after epidural corticosteroid injections. FDA.gov. 2023. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-requires-label-changes-warn-rare-serious-neurologic-problems

  21. Streeten DH, Anderson GH Jr. Adrenal insufficiency in patients receiving long-term corticosteroid therapy. JAMA Intern Med. 1995;155(12):1348-1350. https://pubmed.ncbi.nlm.nih.gov/7779422/

  22. U.S. Food and Drug Administration. Prednisone tablets USP prescribing information. Accessdata.FDA.gov. https://www.accessdata.fda.gov/drugs